Cited by 533Autism Spectrum Disorder ResearchTryptophan and brain disordersGenetics and Neurodevelopmental Disorders

The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index; none of the 212 sources its claims cite is checked for support yet.

The Role of the Immune System in Autism Spectrum Disorder

Open access
Meltzer, Amory, Van de Water, Judy·2017·Neuropsychopharmacology

Abstract

Autism is a neurodevelopmental disorder characterized by deficits in communication and social skills as well as repetitive and stereotypical behaviors. While much effort has focused on the identification of genes associated with autism, research emerging within the past two decades suggests that immune dysfunction is a viable risk factor contributing to the neurodevelopmental deficits observed in autism spectrum disorders (ASD). Further, it is the heterogeneity within this disorder that has brought to light much of the current thinking regarding the subphenotypes within ASD and how the immune system is associated with these distinctions. This review will focus on the two main axes of immune involvement in ASD, namely dysfunction in the prenatal and postnatal periods. During gestation, prenatal insults including maternal infection and subsequent immunological activation may increase the risk of autism in the child. Similarly, the presence of maternally derived anti-brain autoantibodies found in ~20% of mothers whose children are at risk for developing autism has defined an additional subphenotype of ASD. The postnatal environment, on the other hand, is characterized by related but distinct profiles of immune dysregulation, inflammation, and endogenous autoantibodies that all persist within the affected individual. Further definition of the role of immune dysregulation in ASD thus necessitates a deeper understanding of the interaction between both maternal and child immune systems, and the role they have in diagnosis and treatment.

Overview

Integrity signals

Registry

Crossref · 10.1038/npp.2016.158

Cites

160 of 160 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 212 cited sources checked · 0 supported · 0 flagged

Show all 109 claims

  • Probably not a substantial claim. 18
  • It may state two separate claims as one. 75
  • The quote only partly states this claim. 5
88 of 88
  • The paper relies on this without support.

    Findings from animal models of maternal immune activation and maternal autoantibody transfer are informative about the pathogenesis of human ASD.

    “Animal models of MIA have been particularly significant in underscoring the importance of maternal immune regulation.”
    “animal models have been repeatedly utilized to bolster the findings of maternal anti-brain autoantibodies, suggesting a directly causative effect”
  • The paper relies on this without support.

    ASD can be divided into immune-related subphenotypes that are meaningful for diagnosis and treatment.

    “it is the heterogeneity within this disorder that has brought to light much of the current thinking regarding the subphenotypes within ASD and how the immune system is associated with these distinctions”
  • The paper relies on this without support.

    ASD comprises heterogeneous phenotypes that make it difficult to explain behavioral outcomes solely from immune phenotype.

    “given the heterogeneity of ASD phenotypes, it remains difficult to explain different behavioral outcomes based solely on immune phenotype”
3 of 3

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 160 references

Research works printed but not linked: 1

  1. Croen LA, Braunschweig D, Haapanen L, Yoshida CK, Fireman B, Grether JK et al (2008b). Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol Psychiatry 64: 583–588. · DOI

Cited by

Sorted by citations

Items 201–300 of 531

Metadata

Authors
Meltzer, A., & Van de Water, J.
Affiliations
University of California, Davis (US)
Venue
Neuropsychopharmacology
Published
2016-08-18
Volume
42
Issue
1
Pages
284-298
ISSN
  • 0893-133X (ISSN-L)
  • 1740-634X
OpenAlex
W2515862236
Cited by
533
References
160
Citations by year
2026: 48 · 2025: 41 · 2024: 67 · 2023: 57 · 2022: 81 · 2021: 62 · 2020: 77 · 2019: 49 · 2018: 28 · 2017: 20 · 2016: 2
FWCI
3.48
Type
journal article
Language
en
Open access
Locations
  • Neuropsychopharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Institute of Environmental Health Sciences (R01ES015359, P01ES011269)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD079125)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
autism spectrum disorder, immune dysfunction, maternal infection, prenatal immune activation, maternal-fetal immune interaction, neuroinflammation, neurodevelopmental risk factors
MeSH terms
Autism Spectrum Disorder, Animals, Autoantibodies, Brain, Female, Humans, Inflammation, Pregnancy, Pregnancy Complications, Infectious, Prenatal Exposure Delayed Effects

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review